Metabolomic profiling of plasma from glioma and meningioma patients based on two complementary mass spectrometry techniques.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Michal Ciborowski, Adrian Godlewski, Karol Kaminski, Adam Kretowski, Tomasz Lyson, Zenon Mariak, Patrycja Mojsak, Marcin Moniuszko, Tomasz Pienkowski, Joanna Reszec

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: United States : Metabolomics : Official journal of the Metabolomic Society , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 581719

INTRODUCTION: Extracranial and intracranial tumors are a diverse group of malignant and benign neoplasms, influenced by multiple factors. Given the complex nature of these tumors and usually late or accidental diagnosis, minimally invasive, rapid, early, and accurate diagnostic methods are urgently required. Metabolomics offers promising insights into central nervous system tumors by uncovering distinctive metabolic changes linked to tumor development. OBJECTIVES: This study aimed to elucidate the role of altered metabolites and the associated biological pathways implicated in the development of gliomas and meningiomas. METHODS: The study was conducted on 95 patients with gliomas, 68 patients with meningiomas, and 71 subjects as a control group. The metabolic profiling of gliomas and meningiomas achieved by integrating untargeted metabolomic analysis based on GC-MS and targeted analysis performed using LC-MS/MS represents the first comprehensive study. Three comparisons (gliomas or meningiomas vs. controls as well as gliomas vs. meningiomas) were performed to reveal statistically significant metabolites. RESULTS: Comparative analysis revealed 97, 56, and 27 significant metabolites for gliomas vs. controls, meningiomas vs. controls and gliomas vs. meningiomas comparison, respectively. Moreover, among above mentioned comparisons unique metabolites involved in arginine biosynthesis and metabolism, the Krebs cycle, and lysine degradation pathways were found. Notably, 2-aminoadipic acid has been identified as a metabolite that can be used in distinguishing two tumor types. CONCLUSIONS: Our results provide a deeper understanding of the metabolic changes associated with brain tumor development and progression.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH